Image 1 (IMAGE)

National Research Council of Science & Technology

Image 1

Caption

<Photo> Schematic illustration of the operating principle of the plasmonic-based liquid biopsy platform developed by Korea Institute of Materials Science (KIMS).

(The platform detects KRAS mutations associated with colorectal cancer using DNA extracted from tumor tissue, blood, and urine samples. While amplification and fluorescence signal generation are suppressed for wild-type KRAS, mutant KRAS is selectively amplified, producing a strong fluorescence signal. This enables highly sensitive detection of trace amounts of KRAS mutations in blood and urine.)

Credit

Korea Institute of Materials Science (KIMS)

Usage Restrictions

The sources of photos and research results from KIMS must be specified.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.